New Zealand markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.51-0.12 (-2.13%)
At close: 04:00PM EDT
5.52 +0.01 (+0.18%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.63
Bid0.00 x 1300
Ask0.00 x 2900
Day's range5.48 - 5.69
52-week range3.28 - 26.77
Avg. volume1,381,053
Market cap347.166M
Beta (5Y monthly)0.43
PE ratio (TTM)N/A
EPS (TTM)-6.24
Earnings date01 Aug 2022 - 05 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.80
  • Zacks

    Esperion (ESPR) Up More Than 12% YTD: What's Driving the Rally?

    Esperion's (ESPR) marketed drugs are the key drivers of the stock. Sales of the drugs increase more than 100% during the first quarter. Strong sales growth is expected to continue in 2022 as well as 2023.

  • GlobeNewswire

    Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference

    ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will participate in a fireside chat at the upcoming H.C. Wainwright Global Investment Conference on Tuesday, May 24th, 2022. Event:H.C. Wainwright Global Investment ConferenceDate:Tuesday, May 24th, 2022Format:Presentation and 1:1 MeetingsTime:7:00 am Eastern Standard TimeWebcast:Link A live audio webcast can be accessed on the investor and media

  • Simply Wall St.

    Esperion Therapeutics, Inc. (NASDAQ:ESPR): Are Analysts Optimistic?

    Esperion Therapeutics, Inc. ( NASDAQ:ESPR ) is possibly approaching a major achievement in its business, so we would...